Aggravation of ataxia due to acetazolamide induced hyperammonaemia in episodic ataxia [3]

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 78, Issue 7, 2007, Pages 771-772

  Kim, Jeong Min ^a   Ryu, Wi Sun ^a   Hwang, Young Hwan ^b   Ji, Soo Kim ^a  

^a Seoul National University Bundang Hospital   (South Korea)

^b Eulji General Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; AMMONIA;

ADULT; AMMONIA BLOOD LEVEL; ATAXIA; CASE REPORT; DISEASE EXACERBATION; DRUG EFFECT; DRUG RESPONSE; DRUG WITHDRAWAL; HUMAN; HYPERAMMONEMIA; LETTER; MALE; MENTAL DEFICIENCY; METABOLIC ACIDOSIS; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL;

ACETAZOLAMIDE; ACIDOSIS; AMMONIA; ATAXIA; CARBONIC ANHYDRASE INHIBITORS; DISEASE PROGRESSION; HUMANS; MALE; MIDDLE AGED;

EID: 34347223630     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2006.105353     Document Type: Letter

References (5)

1. Gordon N. Episodic ataxia and channelopathies. Brain Dev 1998;20:9-13.
2. Baer E, Reith DM. Acetazolamide poisoning in a toddler. J Paediatr Child Health 2001;37:411-12.
3. Watson WA, Garrelts JC, Zinn PD, et al. Chronic acetazolamide intoxication. J Toxicol Clin Toxicol 1984-1985;22: 549-63.
4. DuBose TD Jr, Good DW, Hamm LL, et al. Ammonium transport in the kidney: new physiological concepts and their clinical implications. J Am Soc Nephrol 1991;1:1193-203.
5. Strupp M, Kalla R, Dichgans M, et al. Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine. Neurology 2004;62:1623-5.